SCHEMBL6918441

SCHEMBL6918441

CC(NC(=O)c1ccc[nH]1)c1ccc(C(=O)NO)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HDAC1 Q13547 6/20 0.49
HDAC6 Q9UBN7 4/20 0.49
HDAC8 Q9BY41 3/20 0.49
NPC1 O15118 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
NR1H4 Q96RI1 1/20 0.45
KMT2A Q03164 1/20 0.43
ROCK2 O75116 1/20 0.43
RPS6KA5 O75582 1/20 0.43
MAP4K4 O95819 1/20 0.43
CDK1 P06493 1/20 0.43
CSF1R P07333 1/20 0.43
PRKACA P17612 1/20 0.43
FLT1 P17948 1/20 0.43
RPS6KB1 P23443 1/20 0.43
CDK2 P24941 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6920062 1.00 ALDH1A1 (0.50) ALDH1A1LMNASMN1; SMN2HDAC1HDAC6
SCHEMBL6919642 0.85 ALDH1A1 (0.50) ALDH1A1LMNASMN1; SMN2HDAC1HDAC6
SCHEMBL15771457 0.84 ALDH1A1 (0.54) ALDH1A1LMNAHDAC1HDAC6NPC1
SCHEMBL15771458 0.84 ALDH1A1 (0.54) ALDH1A1LMNAHDAC1HDAC6NPC1
SCHEMBL6918497 0.81 HDAC6 (0.41) LMNAHDAC1HDAC6HDAC8HDAC3
SCHEMBL2407415 0.79 SMN1; SMN2 (0.77) ALDH1A1LMNASMN1; SMN2HDAC1HDAC6
SCHEMBL6918744 0.78 ROCK2 (0.47) ALDH1A1HDAC1HDAC6HDAC8KMT2A
SCHEMBL6918437 0.76 EGFR (0.58) ALDH1A1LMNASMN1; SMN2HDAC6NPC1
SCHEMBL2413088 0.75 ROCK2 (0.68) ALDH1A1LMNASMN1; SMN2HDAC1HDAC6
SCHEMBL12376697 0.75 KDM4E (0.49) LMNANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106632-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 WO disclosed